Phase I/II Trial of Radiation Therapy and Rituximab for Follicular Lymphoma
A randomized phase I/II trial is underway to evaluate the efficacy of combining radiation therapy with rituximab in patients with stage I-II grade 1 or grade 2 follicular lymphoma, sponsored by M.D. Anderson Cancer Center and NCI.